Merck reports higher first-quarter sales and raises full-year earnings guidance, driven by growing demand for its Keytruda cancer drug.

Cardinal Health Q3 2026 adjusted EPS $3.17 vs est $2.79; raises FY outlook. Revenue $60.9B missed $61.96B est.

Cardinal Health reported third-quarter 2026 adjusted earnings of $3.17 per share, beating estimates, and raised its full-year outlook.

Caterpillar reports Q1 2026 revenue of $17.42 billion and adjusted EPS of $5.54, beating analyst estimates. The company forecasts low double-digit sales growth for the full fiscal year.

Caterpillar reported Q1 2026 revenue of $17.42 billion and adjusted earnings per share of $5.54, both exceeding analyst expectations. The company projects low double-digit growth in sales and revenues for the full fiscal year.

India's Shapoorji and Pallonji Group is in talks with BlackRock, JPMorgan for high-yield bond sale. The discussions come after the group was allowed to delay repayment on existing debt.

India's Shapoorji and Pallonji Group is reportedly in discussions with global investors, including BlackRock and JPMorgan, for a high-yield bond sale, even after being permitted to delay repayment on existing debt, sources say.

Fed holds rates; three dissents over rate-cut bias mark highest since 1992. State Street's Tim Graf says panel aims to signal resistance to political pressure to cut.

The Federal Reserve held interest rates steady, but dissent rose to its highest since 1992 as three policymakers opposed language indicating a bias toward cuts. Tim Graf of State Street said the committee wants to make clear it will resist political pressure to lower rates.